Home Other Building Blocks 189197-69-1
189197-69-1,MFCD05865242
Catalog No.:AA002HYK

189197-69-1 | Ro 48-8071 fumarate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$13.00   $9.00
- +
5mg
95%
in stock  
$16.00   $11.00
- +
10mg
95%
in stock  
$29.00   $20.00
- +
25mg
98%
in stock  
$57.00   $40.00
- +
50mg
98%
in stock  
$75.00   $53.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002HYK
Chemical Name:
Ro 48-8071 fumarate
CAS Number:
189197-69-1
Molecular Formula:
C27H31BrFNO6
Molecular Weight:
564.4405
MDL Number:
MFCD05865242
SMILES:
OC(=O)/C=C/C(=O)O.C=CCN(CCCCCCOc1ccc(c(c1)F)C(=O)c1ccc(cc1)Br)C
Properties
Properties
 
Form:
Solid  
MP:
90-92.7℃  
Storage:
Inert atmosphere;-20 ℃;  

Computed Properties
 
Complexity:
587  
Covalently-Bonded Unit Count:
2  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
14  

Downstream Synthesis Route

[1]CurrentPatentAssignee:UNIVERSITYOFMISSOURISYSTEM-WO2014/4854,2014,A1

[1]CurrentPatentAssignee:UNIVERSITYOFMISSOURISYSTEM-WO2014/4854,2014,A1Locationinpatent:Paragraph0199

[1]CurrentPatentAssignee:UNIVERSITYOFMISSOURISYSTEM-WO2014/4854,2014,A1

[1]CurrentPatentAssignee:UNIVERSITYOFMISSOURISYSTEM-WO2014/4854,2014,A1

[1]CurrentPatentAssignee:UNIVERSITYOFMISSOURISYSTEM-WO2014/4854,2014,A1

Literature

Title: Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.

Journal: Journal of medicinal chemistry 20120614

Title: Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.

Journal: Bioorganic & medicinal chemistry letters 20090201

Title: Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors.

Journal: Journal of medicinal chemistry 20030717

Title: Morand OH, et al. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin. J Lipid Res. 1997 Feb;38(2):373-90.

Title: Liang Y, et al. Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells. Onco Targets Ther. 2016 May 30;9:3223-32

Title: Liang Y, et al. Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071. Breast Cancer Res Treat. 2014 Jul;146(1):51-62.

Title: Chuang JC, et al. Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse. Biochem Pharmacol. 2014 Apr 1;88(3):351-63.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 189197-69-1
Tags:189197-69-1 Molecular Formula|189197-69-1 MDL|189197-69-1 SMILES|189197-69-1 Ro 48-8071 fumarate